RE: Always a chance of a buy out26 Jan 2024 18:32
With respect dosanddonts,i don't think we can draw any conclusions regarding fum's knowledge of the canada situation one way or the other. if you are suggesting that one of their licensing partners has launched without their knowledge or approval, i would find the suggestion extremely unlikely and hardy conductive to a positive ongoing commercial relationship(not to mention the highly likely prospect of litigation resulting).if it is a totally unauthorised marketing by a non licensee, then again legal redress must surely be in the offing(as well as appropriate injunctions to prevent its continuation).if it is some form of soft launch sanctioned by fum,but not yet announced to the market,then it should be viewed(imo) as a positive.personally i suspect the implications of the apparent marketing in canada are simply not yet properly understood by investors,particularly bearing in mind that fum do not appear to have authorisation to market otc in canada (the fda approval doesn't encompass canada which has its own authorisation requirements).so whilst i do accept that some clarification of the situation from the bod would be desirable,i do not think that it has to be construed as demonstrating incompetence or lack of control on fum's part. where i do agree though is that a T/O is the ultimate aim here,which is imo,the only way L/O can exit and realise its 28.5% position. minimum of 100p imo